Medicare Enrolled

Dr. Jeremiah Johns, MD

Anesthesiology · Grand Rapids, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
109 MICHIGAN ST NW STE 200, Grand Rapids, MI 49503
6163302522
In practice since 2006 (19 years)
NPI: 1184786824 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Johns from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Johns? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Johns

Dr. Jeremiah Johns is an anesthesiology specialist in Grand Rapids, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Johns performed 2,248 Medicare services across 59 unique beneficiaries.

Between the years covered by Open Payments, Dr. Johns received a total of $2,402 from 5 pharmaceutical and/or device companies across 9 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Johns is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 3% volume in MI $2,402 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,248
Medicare services
Top 3% in MI for anesthesiology
59
Unique beneficiaries
$192
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~118 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Lutetium Lu 177 vipivotide tetraxetan therapeutic injection
A therapeutic injection of Lutetium Lu 177 vipivotide tetraxetan administered in units of millicuries.
2,200 $194 $741
Emergency department visit, high complexity
An emergency department visit involving a high level of medical decision making.
25 $138 $903
Radioactive drug therapy through a vein
Administration of a radioactive medication directly into the bloodstream via an intravenous line.
12 $114 $425
Emergency department visit, moderate complexity
An emergency department visit for an established or new patient involving a moderate level of medical decision making.
11 $100 $620
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,402
Total received (2018-2024)
Avg $801/year across 3 years
Top 8% in MI for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
5
Companies
9
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,970 (82.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$432 (18.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$153
2023
$280
2018
$1,970

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Life Molecular Imaging Ltd
$135
Eisai Inc.
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$1,970
Telix Pharmaceuticals
$145
Novartis Pharmaceuticals Corporation
$135
Life Molecular Imaging Ltd
$135
Eisai Inc.
$18
Top 3 companies account for 93.6% of all-time payments
Associated products mentioned in payments ›
ILLUCCIX · LUTATHERA · Leqembi · NEURACEQ · PLUVICTO · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in anesthesiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for anesthesiology in MI.

Looking for an anesthesiology specialist in Grand Rapids?
Compare anesthesiologists in the Grand Rapids area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologists nearby

Geographic Context

Anesthesiologists within 10 mi
242
Per 100K population
36.7
County median income
$80,390
Nearest hospital
SPECTRUM HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Johns is a mixed practice specialist, with above-average Medicare volume (top 3% in MI), with speaking/promotional industry engagement in the top 8% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Johns experienced with lutetium lu 177 vipivotide tetraxetan therapeutic injection?
Based on Medicare claims data, Dr. Johns performed 2,200 lutetium lu 177 vipivotide tetraxetan therapeutic injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Johns receive payments from pharmaceutical companies?
Yes. Dr. Johns received a total of $2,402 from 5 companies across 9 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Johns's costs compare to other anesthesiologists in Grand Rapids?
Dr. Johns's average Medicare payment per service is $192. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Johns) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →